Triple blockade with LEE011, everolimus, and exemestane in women with ER+/HER2– advanced/metastatic breast cancer: results from a Phase Ib clinical trial. (European Journal of Cancer 2014, 50(suppl 6): p163)
Refereed conference paper presented and published in conference proceedings


Full Text

Other information
All Author(s) ListBARDIA A, CHAVEZ-MACGREGOR M, MODI S, CAMPONE M, MA Buig Yue Brigette, KITTANEH M, DIRIX D, MOTTA M, ZHANG V, BHANSALI S, FJAELLSKOG M, OLIVEIRA M
Name of Conference26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Start Date of Conference18/11/2014
Country/Region of ConferenceSpain
Proceedings Title26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Detailed descriptionorganized by European Cancer Organisation,
Year2014
Month11
Day18
Place of PublicationSpain
LanguagesEnglish-United Kingdom
Keywordseverolimus; metastatic breast cancer

Last updated on 2018-24-01 at 13:35